Dimerix’s lead clinical asset DMX-200 will be available to eligible patients through post-trial access pathways in key ...
DemeRx, Inc., a clinical-stage biopharmaceutical company dedicated to transforming addiction therapeutics, today announced ...
PHOENIX — Rapper DMX has been arrested for the second time in a week, this time after he was indicted on felony drug possession and misdemeanor animal cruelty charges. The Maricopa County sheriff’s ...
Michael Kay jokingly invited DMX to record a song for YES Network, only to be informed DMX is no longer available. Thursday ...
Detailed price information for District Metals Corp (DMX-X) from The Globe and Mail including charting and trades.
Everest Medicines has signed an exclusive licensing agreement with Dimerix to develop and commercialize DMX-200 across Asia-Pacific. The deal focuses on treating serious kidney diseases such as focal ...
Dimerix Limited, a clinical-stage biopharmaceutical company in Australia, announced that it has entered into an exclusive license agreement with Everest Medicines, Shanghai, China for the ...
DMX’s street naming is still ringing bells, but the chatter continues. Last weekend was a tumultuous one. There was a lot going on, but it end off with something genuinely meaningful on Friday. Earl ...
MELBOURNE, Australia, June 16, 2026 /PRNewswire/ -- Dimerix Limited (ASX: DXB, "Dimerix") today announced that it has entered into an exclusive license agreement with Everest Medicines for the ...
Dimerix inks exclusive DMX-200 FSGS deal with Everest in Asia; upfront $14.1m, potential milestones up to ~$466m and 15% royalties. Dimerix (ASX: DXB) has entered into an exclusive licence agreement ...
Everest Medicines licenses exclusive rights to commercialise DMX-200 for the treatment of Focal Segmental Glomerulosclerosis (FSGS) in Greater China, South Korea and Southeast Asia 500,000-1 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results